title: FTY720: a novel transplantation drug that modulates lymphocyte traffic rather than activation.
authors.affiliation: Transplantation Research, Novartis Pharma AG, Transplantation Research, WSJ-386.1.25, CH-4002 Basel, Switzerland. volker.brinkmann@pharma.novartis.com
authors.forename: V
authors.initials: V
authors.lastname: Brinkmann
authors.forename: D
authors.initials: D
authors.lastname: Pinschewer
authors.forename: K
authors.initials: K
authors.lastname: Chiba
authors.forename: L
authors.initials: L
authors.lastname: Feng
mesh_terms: D002465:Cell Movement / Q000187:drug effects; D000068876:Fingolimod Hydrochloride; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000494:pharmacology*; D008213:Lymphocyte Activation / Q000187:drug effects; D016131:Lymphocyte Subsets / Q000187:drug effects* / Q000276:immunology; D016377:Organ Transplantation; D011409:Propylene Glycols / Q000009:adverse effects / Q000494:pharmacology*; D020011:Protective Agents / Q000494:pharmacology; D013110:Sphingosine / Q000031:analogs & derivatives; D014184:Transplantation, Homologous
chemical_list: D007166:Immunosuppressive Agents; D011409:Propylene Glycols; D020011:Protective Agents; D000068876:Fingolimod Hydrochloride; D013110:Sphingosine